iiCON at the heart of infectious disease research This year, a new AI robotic laboratory designed to accelerate the discovery of drugs and vaccines for infectious diseases was announced in Liverpool UK. The £20 million ($26.4 million) Liverpool Accelerate Laboratory was developed through the Infection Innovation Consortium: iiCON – an initiative dedicated… Read More
The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies. Launched in… Read More
The pharmacological behaviour of drugs is determined not only by their intrinsic properties but also by the sensitivity of the biological systems in which they are evaluated. Variations in receptor density and signal transduction efficiency can significantly influence observed drug responses, complicating the translation of in vitro findings to in… Read More
The global informatics market is expected to triple in size in the next ten years. These technologies are speeding up the process of drug development, but also enabling better accuracy, more precision, more reproducibility and ultimately, better science. This eBook explores the latest developments in artificial… Read More
Hosted by Drug Discovery World and supported by Bio-Techne this webinar will explore the advances and challenges taking place within the cell and gene therapy field. You will hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo… Read More
A new eBook titled ‘Accelerating drug discovery with rational design’ is now available exclusively to DDW readers from Thermo Fisher Scientific. The eBook explores real-world examples demonstrating how high-resolution structural insights can inform earlier decisions, illuminate mechanisms of action, and help reduce the time, cost, and risk associated with advancing… Read More
This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More
News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories: In-person… Read More
R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More
The Drug Discovery Innovators & Investors (DDII) UK Conference has announced a new panel, From Rules to Runway: How UK Regulation Can Accelerate or Obstruct Drug Development, examining how organisations can navigate the UK regulatory environment while supporting innovation and accelerating the development of new therapies. The conference takes place… Read More
In this series, DDW speaks to women in leading positions across biopharma about the work they’re doing and their experiences within the industry. Here, we speak to Charlotte Edenius, Gesynta, co-founder and VP of R&D Strategy of Gesynta Pharma about the company’s approach to treating pain and inflammation and… Read More
The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More
The latest episode of the DDW Sitting Down With vodcast is sponsored by ProBio, and our guest is Derek Chen, who Multimedia Editor Megan Thomas interviewed on how AI is transforming antibody drug discovery, from identifying and prioritising candidates to early developability assessment, experimental validation and the integration of discovery,… Read More
Seventeen new companies will now benefit from BioInnovation Institute (BII)’s innovation platform, which helps companies attract capital and bring promising technologies to market. The innovation house is providing a total of around €9.5 million. Following the announcement of a new €736 million from the Novo Nordisk Foundation to the BII,… Read More
